Kevin Markey

419 total citations
23 papers, 285 citations indexed

About

Kevin Markey is a scholar working on Microbiology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Kevin Markey has authored 23 papers receiving a total of 285 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Microbiology, 13 papers in Epidemiology and 9 papers in Infectious Diseases. Recurrent topics in Kevin Markey's work include Bacterial Infections and Vaccines (14 papers), Pneumonia and Respiratory Infections (9 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Kevin Markey is often cited by papers focused on Bacterial Infections and Vaccines (14 papers), Pneumonia and Respiratory Infections (9 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Kevin Markey collaborates with scholars based in United Kingdom, Finland and China. Kevin Markey's co-authors include Qiushui He, Dorothy Xing, Alex‐Mikael Barkoff, Peter Rigsby, Jussi Mertsola, Norman K. Fry, Jason Hockley, Mei Mei Ho, Ian M. Feavers and Guy A. M. Berbers and has published in prestigious journals such as Analytical Biochemistry, Journal of Clinical Microbiology and Frontiers in Immunology.

In The Last Decade

Kevin Markey

22 papers receiving 268 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kevin Markey United Kingdom 11 187 176 77 51 34 23 285
Larissa van der Maas Netherlands 9 234 1.3× 202 1.1× 61 0.8× 55 1.1× 66 1.9× 16 314
Maja Jahnmatz Sweden 6 163 0.9× 182 1.0× 66 0.9× 85 1.7× 30 0.9× 6 296
Andrea M. DiVenere United States 8 88 0.5× 73 0.4× 52 0.7× 18 0.4× 64 1.9× 10 191
Kina Helm Netherlands 9 160 0.9× 154 0.9× 78 1.0× 43 0.8× 27 0.8× 10 269
Lotte H. Hendrikx Netherlands 11 360 1.9× 346 2.0× 105 1.4× 63 1.2× 21 0.6× 12 433
M Tiru Sweden 9 309 1.7× 225 1.3× 80 1.0× 54 1.1× 66 1.9× 12 405
Kumaran Vadivelu United States 8 284 1.5× 259 1.5× 34 0.4× 25 0.5× 27 0.8× 13 335
Hitt Sharma India 10 58 0.3× 116 0.7× 65 0.8× 39 0.8× 14 0.4× 28 206
Sophie Lecher France 9 69 0.4× 196 1.1× 193 2.5× 92 1.8× 40 1.2× 16 283
Marta Valente Pinto United Kingdom 9 109 0.6× 152 0.9× 50 0.6× 47 0.9× 41 1.2× 20 242

Countries citing papers authored by Kevin Markey

Since Specialization
Citations

This map shows the geographic impact of Kevin Markey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Markey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Markey more than expected).

Fields of papers citing papers by Kevin Markey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin Markey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Markey. The network helps show where Kevin Markey may publish in the future.

Co-authorship network of co-authors of Kevin Markey

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin Markey. A scholar is included among the top collaborators of Kevin Markey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin Markey. Kevin Markey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Care, Rory, Peter Rigsby, Kevin Markey, et al.. (2023). Variability of in vivo potency assays of whole-cell pertussis, inactivated polio, and meningococcal B vaccines. Vaccine. 41(38). 5603–5613. 1 indexed citations
3.
Dalby, Tine, Alex‐Mikael Barkoff, Charlotte Sværke Jørgensen, et al.. (2020). Differences in epitope‐specific antibodies to pertussis toxin after infection and acellular vaccinations. Clinical & Translational Immunology. 9(8). e1161–e1161. 7 indexed citations
4.
5.
Markey, Kevin, et al.. (2019). Assays for Determining Pertussis Toxin Activity in Acellular Pertussis Vaccines. Toxins. 11(7). 417–417. 13 indexed citations
6.
Markey, Kevin, Norman K. Fry, Alex‐Mikael Barkoff, et al.. (2019). Improvement in serological diagnosis of pertussis by external quality assessment. Journal of Medical Microbiology. 68(5). 741–747. 11 indexed citations
7.
Barkoff, Alex‐Mikael, Jussi Mertsola, Denis Piérard, et al.. (2019). Pertactin-deficient Bordetella pertussis isolates: evidence of increased circulation in Europe, 1998 to 2015. Eurosurveillance. 24(7). 67 indexed citations
8.
Markey, Kevin, et al.. (2018). Calibration of pertussis toxin BRP batch 1 in a standardised CHO cell-based clustering assay.. PubMed. 2018. 112–123. 9 indexed citations
9.
Barkoff, Alex‐Mikael, Jussi Mertsola, Denis Piérard, et al.. (2018). Surveillance of Circulating Bordetella pertussis Strains in Europe during 1998 to 2015. Journal of Clinical Microbiology. 56(5). 32 indexed citations
10.
Tanley, S.W.M., et al.. (2017). An ELISA method to estimate the mono ADP-ribosyltransferase activities: e.g in pertussis toxin and vaccines. Analytical Biochemistry. 540-541. 15–19. 7 indexed citations
11.
Markey, Kevin, et al.. (2017). Development of an in vitro Biochemical Assay System for the Measurement of Residual Toxin Activities in Pertussis Toxin Containing Vaccines. Journal of Vaccines & Vaccination. 8(2). 4 indexed citations
12.
Isbrucker, Richard, Camille Locht, Juan Arciniega, et al.. (2016). In search of acceptable alternatives to the murine histamine sensitisation test (HIST): what is possible and practical?. PubMed. 2016. 151–170. 6 indexed citations
13.
Xing, Dorothy, Kevin Markey, Rose Gaines Das, & Ian M. Feavers. (2014). Whole-cell pertussis vaccine potency assays: the Kendrick test and alternative assays. Expert Review of Vaccines. 13(10). 1175–1182. 14 indexed citations
14.
Barkoff, Alex‐Mikael, Nicole Guiso, Sophie Guillot, et al.. (2014). A rapid ELISA-based method for screening Bordetella pertussis strain production of antigens included in current acellular pertussis vaccines. Journal of Immunological Methods. 408. 142–148. 10 indexed citations
15.
16.
Markey, Kevin, et al.. (2011). An assessment of thermal stability ofClostridium difficiletoxoid formulations. Human Vaccines. 7(2). 202–210. 2 indexed citations
17.
Xing, Dorothy, et al.. (2011). EUVAC.NET collaborative study: Evaluation and standardisation of serology for diagnosis of pertussis. Journal of Immunological Methods. 372(1-2). 137–145. 18 indexed citations
18.
Markey, Kevin, Mei Mei Ho, Ju Liu, et al.. (2010). Report of an international collaborative study to evaluate the suitability of multiplex PCR as an identity assay for different sub-strains of BCG vaccine. Vaccine. 28(43). 6964–6969. 17 indexed citations
19.
Ho, Mei Mei, Kevin Markey, Peter Rigsby, Jason Hockley, & Michael J. Corbel. (2010). Report of an International collaborative study to establish the first WHO reference reagents for BCG vaccines of three different sub-strains. Vaccine. 29(3). 512–518. 15 indexed citations
20.
Mullen, Thomas J., Kevin Markey, Philip G. Murphy, Siobhán McClean, & M. Callaghan. (2007). Role of lipase in Burkholderia cepacia complex (Bcc) invasion of lung epithelial cells. European Journal of Clinical Microbiology & Infectious Diseases. 26(12). 869–877. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Larissa van der Maas Breakdown of academic impact, for papers by Maja Jahnmatz Breakdown of academic impact, for papers by Andrea M. DiVenere Breakdown of academic impact, for papers by Kina Helm Breakdown of academic impact, for papers by Lotte H. Hendrikx Breakdown of academic impact, for papers by M Tiru Breakdown of academic impact, for papers by Kumaran Vadivelu Breakdown of academic impact, for papers by Hitt Sharma Breakdown of academic impact, for papers by Sophie Lecher Breakdown of academic impact, for papers by Marta Valente Pinto
Rankless by CCL
2026